233 related articles for article (PubMed ID: 8473043)
21. The CD2-scl transgene alters the phenotype and frequency of T-lymphomas in N-ras transgenic or p53 deficient mice.
Curtis DJ; Robb L; Strasser A; Begley CG
Oncogene; 1997 Dec; 15(24):2975-83. PubMed ID: 9416841
[TBL] [Abstract][Full Text] [Related]
22. A full-length Notch1 allele is dispensable for transformation associated with a provirally activated truncated Notch1 allele in Moloney MuLV-infected MMTV(D)/myc transgenic mice.
Girard L; Jolicoeur P
Oncogene; 1998 Jan; 16(4):517-22. PubMed ID: 9484841
[TBL] [Abstract][Full Text] [Related]
23. Characterization of pal-1, a common proviral insertion site in murine leukemia virus-induced lymphomas of c-myc and Pim-1 transgenic mice.
Scheijen B; Jonkers J; Acton D; Berns A
J Virol; 1997 Jan; 71(1):9-16. PubMed ID: 8985317
[TBL] [Abstract][Full Text] [Related]
24. Genomic structure and precise mapping of a thymic regulatory region on mouse chromosome 17 revealed by a c-myc transgene insertion.
Lavenu A; Roland J; Poirier C; Cazenave P; Babinet C; Morello D
Genomics; 1996 Jun; 34(3):381-8. PubMed ID: 8786139
[TBL] [Abstract][Full Text] [Related]
25. Selection for c-myc integration sites in polyclonal T-cell lymphomas.
Broussard DR; Mertz JA; Lozano M; Dudley JP
J Virol; 2002 Mar; 76(5):2087-99. PubMed ID: 11836386
[TBL] [Abstract][Full Text] [Related]
26. Immunophenotypic and antigen receptor gene rearrangement analysis in T cell neoplasia.
Knowles DM
Am J Pathol; 1989 Apr; 134(4):761-85. PubMed ID: 2495724
[TBL] [Abstract][Full Text] [Related]
27. H-2/myc, E mu/myc, and c-myc transgenic mice: potent sources of early hematopoietic cell lines.
Roland J; Morello D
Cell Growth Differ; 1993 Nov; 4(11):891-900. PubMed ID: 8297795
[TBL] [Abstract][Full Text] [Related]
28. Activation of the c-H-ras proto-oncogene by retrovirus insertion and chromosomal rearrangement in a Moloney leukemia virus-induced T-cell leukemia.
Ihle JN; Smith-White B; Sisson B; Parker D; Blair DG; Schultz A; Kozak C; Lunsford RD; Askew D; Weinstein Y
J Virol; 1989 Jul; 63(7):2959-66. PubMed ID: 2542606
[TBL] [Abstract][Full Text] [Related]
29. Phenotypes of murine leukemia virus-induced tumors: influence of 3' viral coding sequences.
Ott DE; Keller J; Sill K; Rein A
J Virol; 1992 Oct; 66(10):6107-16. PubMed ID: 1326661
[TBL] [Abstract][Full Text] [Related]
30. Fas-independent apoptosis in T-cell tumours induced by the CD2-myc transgene.
Cameron ER; Morton J; Johnston CJ; Irvine J; Bell M; Onions DE; Neil JC; Campbell M; Blyth K
Cell Death Differ; 2000 Jan; 7(1):80-8. PubMed ID: 10713723
[TBL] [Abstract][Full Text] [Related]
31. Myeloid, B and T lymphoid and mixed lineage thymic lymphomas in the irradiated mouse.
Boulton E; Cleary H; Plumb M
Carcinogenesis; 2002 Jun; 23(6):1079-85. PubMed ID: 12082032
[TBL] [Abstract][Full Text] [Related]
32. Activation of multiple genes by provirus integration in the Mlvi-4 locus in T-cell lymphomas induced by Moloney murine leukemia virus.
Tsichlis PN; Lee JS; Bear SE; Lazo PA; Patriotis C; Gustafson E; Shinton S; Jenkins NA; Copeland NG; Huebner K
J Virol; 1990 May; 64(5):2236-44. PubMed ID: 1691313
[TBL] [Abstract][Full Text] [Related]
33. Transgenic N-myc mouse model for indolent B cell lymphoma: tumor characterization and analysis of genetic alterations in spontaneous and retrovirally accelerated tumors.
Sheppard RD; Samant SA; Rosenberg M; Silver LM; Cole MD
Oncogene; 1998 Oct; 17(16):2073-85. PubMed ID: 9798678
[TBL] [Abstract][Full Text] [Related]
34. Provirus integration at the 3' region of N-myc in cell lines established from thymic lymphomas spontaneously formed in AKR mice and a [(BALB/c x B6)F1----AKR] bone marrow chimera.
Yano Y; Kobayashi S; Yasumizu R; Tamaki J; Kubo M; Sasaki A; Hasan S; Okuyama H; Inaba M; Ikehara S
Jpn J Cancer Res; 1991 Feb; 82(2):176-83. PubMed ID: 1900822
[TBL] [Abstract][Full Text] [Related]
35. Fc gamma RII/III and CD2 expression mark distinct subpopulations of immature CD4-CD8- murine thymocytes: in vivo developmental kinetics and T cell receptor beta chain rearrangement status.
Rodewald HR; Awad K; Moingeon P; D'Adamio L; Rabinowitz D; Shinkai Y; Alt FW; Reinherz EL
J Exp Med; 1993 Apr; 177(4):1079-92. PubMed ID: 8096236
[TBL] [Abstract][Full Text] [Related]
36. E mu N- and E mu L-myc cooperate with E mu pim-1 to generate lymphoid tumors at high frequency in double-transgenic mice.
Möröy T; Verbeek S; Ma A; Achacoso P; Berns A; Alt F
Oncogene; 1991 Nov; 6(11):1941-8. PubMed ID: 1658705
[TBL] [Abstract][Full Text] [Related]
37. Skewed T-cell receptor Vbeta8.2 expression in transgenic CD2-myc induced thymic lymphoma: a role for antigen stimulation in tumour development?
Webster G; Onions DE; Neil JC; Cameron ER
Br J Cancer; 1997; 76(6):739-46. PubMed ID: 9310239
[TBL] [Abstract][Full Text] [Related]
38. Brain tumours and lymphomas in transgenic mice that carry HTLV-I LTR/c-myc and Ig/tax genes.
Benvenisty N; Ornitz DM; Bennett GL; Sahagan BG; Kuo A; Cardiff RD; Leder P
Oncogene; 1992 Dec; 7(12):2399-405. PubMed ID: 1461648
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of Ras, Raf and L-myc but not Bcl-2 family proteins is linked with resistance to TCR-mediated apoptosis and tumorigenesis in thymic lymphomas from TCR transgenic mice.
Kobzdej M; Matuszyk J; Strzadala L
Leuk Res; 2000 Jan; 24(1):33-8. PubMed ID: 10634643
[TBL] [Abstract][Full Text] [Related]
40. Leukaemogenesis by the delta Mo + SV Moloney murine leukaemia virus (M-MuLV) variant in E mu pim-1 transgenic mice: high frequency of recombination with a solo endogenous M-MuLV LTR in vivo.
Suchman EL; Pattengale PK; Fan H
J Gen Virol; 1995 Feb; 76 ( Pt 2)():347-56. PubMed ID: 7844555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
